In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
After finishing at $1.62 in the prior trading day, Telomir Pharmaceuticals Inc (NASDAQ: TELO) closed at $1.57, down -3.09%. In other words, the price has decreased by -$3.09 from its previous closing price. On the day, 0.54 million shares were traded. TELO stock price reached its highest trading level at $1.64 during the session, while it also had its lowest trading level at $1.52.
Ratios:
Our goal is to gain a better understanding of TELO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.38 and its Current Ratio is at 2.38. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on February 21, 2025, initiated with a Buy rating and assigned the stock a target price of $15.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TELO now has a Market Capitalization of 53114620 and an Enterprise Value of 50020232.
Stock Price History:
The Beta on a monthly basis for TELO is -0.83, which has changed by -0.6374134 over the last 52 weeks, in comparison to a change of 0.13837254 over the same period for the S&P500. Over the past 52 weeks, TELO has reached a high of $7.08, while it has fallen to a 52-week low of $1.12. The 50-Day Moving Average of the stock is 7.27%, while the 200-Day Moving Average is calculated to be -40.41%.
Shares Statistics:
The stock has traded on average 5.53M shares per day over the past 3-months and 7211860 shares per day over the last 10 days, according to various share statistics. A total of 30.51M shares are outstanding, with a floating share count of 14.48M. Insiders hold about 55.16% of the company’s shares, while institutions hold 8.72% stake in the company. Shares short for TELO as of 1759190400 were 1314090 with a Short Ratio of 0.24, compared to 1756425600 on 3249510. Therefore, it implies a Short% of Shares Outstanding of 1314090 and a Short% of Float of 5.55.
Earnings Estimates
Investors are keenly observing as 1 analysts analyze and rate. The current performance of Telomir Pharmaceuticals Inc (TELO) in the stock market.The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.07 and low estimates of -$0.07.
Analysts are recommending an EPS of between -$0.38 and -$0.38 for the fiscal current year, implying an average EPS of -$0.38. EPS for the following year is -$0.28, with 1.0 analysts recommending between -$0.28 and -$0.28.
Revenue Estimates
Based on 1 analysts’ estimates, the company’s revenue will be $1.5M in the next fiscal year. The high estimate is $1.5M and the low estimate is $1.5M.
